101 related articles for article (PubMed ID: 27079716)
1. Monophosphoryl Lipid-A: A Promising Tool for Alzheimer's Disease Toll.
Rego Â; Viana SD; Ribeiro CA; Rodrigues-Santos P; Pereira FC
J Alzheimers Dis; 2016 Apr; 52(4):1189-202. PubMed ID: 27079716
[TBL] [Abstract][Full Text] [Related]
2. Monophosphoryl lipid A is an lipopolysaccharide-derived Toll-like receptor 4 agonist which may improve Alzheimer's disease pathology.
Wang DB
Expert Opin Biol Ther; 2013 Dec; 13(12):1639-41. PubMed ID: 24074146
[TBL] [Abstract][Full Text] [Related]
3. Early minor stimulation of microglial TLR2 and TLR4 receptors attenuates Alzheimer's disease-related cognitive deficit in rats: behavioral, molecular, and electrophysiological evidence.
Pourbadie HG; Sayyah M; Khoshkholgh-Sima B; Choopani S; Nategh M; Motamedi F; Shokrgozar MA
Neurobiol Aging; 2018 Oct; 70():203-216. PubMed ID: 30031930
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer's disease-related pathology.
Michaud JP; Hallé M; Lampron A; Thériault P; Préfontaine P; Filali M; Tribout-Jover P; Lanteigne AM; Jodoin R; Cluff C; Brichard V; Palmantier R; Pilorget A; Larocque D; Rivest S
Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1941-6. PubMed ID: 23322736
[TBL] [Abstract][Full Text] [Related]
5. Prestimulation of Microglia Through TLR4 Pathway Promotes Interferon Beta Expression in a Rat Model of Alzheimer's Disease.
Yousefi N; Sotoodehnejadnematalahi F; Heshmati-Fakhr N; Sayyah M; Hoseini M; Ghassemi S; Aliakbari S; Pourbadie HG
J Mol Neurosci; 2019 Apr; 67(4):495-503. PubMed ID: 30610591
[TBL] [Abstract][Full Text] [Related]
6. Microglial response to LPS increases in wild-type mice during aging but diminishes in an Alzheimer's mouse model: Implication of TLR4 signaling in disease progression.
Go M; Kou J; Lim JE; Yang J; Fukuchi KI
Biochem Biophys Res Commun; 2016 Oct; 479(2):331-337. PubMed ID: 27641666
[TBL] [Abstract][Full Text] [Related]
7. Role of toll-like receptor signalling in Abeta uptake and clearance.
Tahara K; Kim HD; Jin JJ; Maxwell JA; Li L; Fukuchi K
Brain; 2006 Nov; 129(Pt 11):3006-19. PubMed ID: 16984903
[TBL] [Abstract][Full Text] [Related]
8. Methods to monitor monocytes-mediated amyloid-beta uptake and phagocytosis in the context of adjuvanted immunotherapies.
Hallé M; Tribout-Jover P; Lanteigne AM; Boulais J; St-Jean JR; Jodoin R; Girouard MP; Constantin F; Migneault A; Renaud F; Didierlaurent AM; Mallett CP; Burkhart D; Pilorget A; Palmantier R; Larocque D
J Immunol Methods; 2015 Sep; 424():64-79. PubMed ID: 26002154
[TBL] [Abstract][Full Text] [Related]
9. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
10. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease.
Cai Z; Hussain MD; Yan LJ
Int J Neurosci; 2014 May; 124(5):307-21. PubMed ID: 23930978
[TBL] [Abstract][Full Text] [Related]
11. Monophosphoryl lipid A induced innate immune responses via TLR4 to enhance clearance of nontypeable Haemophilus influenzae and Moraxella catarrhalis from the nasopharynx in mice.
Hirano T; Kodama S; Kawano T; Maeda K; Suzuki M
FEMS Immunol Med Microbiol; 2011 Dec; 63(3):407-17. PubMed ID: 22092567
[TBL] [Abstract][Full Text] [Related]
12. Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease.
Walter S; Letiembre M; Liu Y; Heine H; Penke B; Hao W; Bode B; Manietta N; Walter J; Schulz-Schuffer W; Fassbender K
Cell Physiol Biochem; 2007; 20(6):947-56. PubMed ID: 17982277
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptors in Alzheimer's disease: a therapeutic perspective.
Gambuzza ME; Sofo V; Salmeri FM; Soraci L; Marino S; Bramanti P
CNS Neurol Disord Drug Targets; 2014; 13(9):1542-58. PubMed ID: 25106635
[TBL] [Abstract][Full Text] [Related]
14. Cytokine-producing microglia have an altered beta-amyloid load in aged APP/PS1 Tg mice.
Babcock AA; Ilkjær L; Clausen BH; Villadsen B; Dissing-Olesen L; Bendixen AT; Lyck L; Lambertsen KL; Finsen B
Brain Behav Immun; 2015 Aug; 48():86-101. PubMed ID: 25774009
[TBL] [Abstract][Full Text] [Related]
15. MPL Adjuvant Contains Competitive Antagonists of Human TLR4.
Wang YQ; Bazin-Lee H; Evans JT; Casella CR; Mitchell TC
Front Immunol; 2020; 11():577823. PubMed ID: 33178204
[TBL] [Abstract][Full Text] [Related]
16. TLR4 is a link between diabetes and Alzheimer's disease.
Huang NQ; Jin H; Zhou SY; Shi JS; Jin F
Behav Brain Res; 2017 Jan; 316():234-244. PubMed ID: 27591966
[TBL] [Abstract][Full Text] [Related]
17. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
18. EGb761 improves cognitive function and regulates inflammatory responses in the APP/PS1 mouse.
Wan W; Zhang C; Danielsen M; Li Q; Chen W; Chan Y; Li Y
Exp Gerontol; 2016 Aug; 81():92-100. PubMed ID: 27220811
[TBL] [Abstract][Full Text] [Related]
19. Toll-Like Receptor 4: A Promising Therapeutic Target for Alzheimer's Disease.
Wu L; Xian X; Xu G; Tan Z; Dong F; Zhang M; Zhang F
Mediators Inflamm; 2022; 2022():7924199. PubMed ID: 36046763
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the adjuvant effect of agonists of toll-like receptor 4 and 7/8 in a vaccine against leishmaniasis in BALB/c mice.
Rostamian M; Niknam HM
Mol Immunol; 2017 Nov; 91():202-208. PubMed ID: 28963929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
